finance.yahoo.com/news/irla...
irlab.se/project-portfolio/...
Pirepemat (IRL752) is being developed to improve balance and reduce falls, and thus injuries from falls, in people living with Parkinson’s. Falls are a significant consequence of Parkinson’s that has severe complications, such as fractures, impaired mobility and reduced quality of life. Impaired balance and falls are linked to cognitive decline and the progression of Parkinson’s disease.